These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 21729953)

  • 1. Coverage of highly active antiretroviral therapy among postpartum women in Malawi.
    Kumwenda J; Matchere F; Mataya R; Chen S; Mipando L; Li Q; Kumwenda NI; Taha TE
    Int J STD AIDS; 2011 Jul; 22(7):368-72. PubMed ID: 21729953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
    Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
    Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi.
    Weigel R; Hosseinipour MC; Feldacker C; Gareta D; Tweya H; Chiwoko J; Gumulira J; Kalulu M; Mofolo I; Kamanga E; Mwale G; Kadzakumanja A; Jere E; Phiri S
    Trop Med Int Health; 2012 Jun; 17(6):751-9. PubMed ID: 22487553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.
    Schwartz SR; Kumwenda N; Kumwenda J; Chen S; Mofenson LM; Taylor AW; Fowler MG; Taha TE
    Matern Child Health J; 2016 Mar; 20(3):542-9. PubMed ID: 26525557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
    Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T
    J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retention, transfer out and loss to follow-up two years after delivery in a cohort of HIV+ pregnant women in Malawi.
    Giuliano M; Liotta G; Andreotti M; Mancinelli S; Buonomo E; Scarcella P; Amici R; Jere H; Sagno JB; Di Gregorio M; Marazzi MC; Vella S; Palombi L
    Int J STD AIDS; 2016 May; 27(6):462-8. PubMed ID: 25953961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi.
    Galluzzo C; Liotta G; Andreotti M; Luhanga R; Jere H; Mancinelli S; Maulidi M; Sagno JB; Pirillo M; Erba F; Amici R; Ceffa S; Marazzi MC; Vella S; Palombi L; Giuliano M
    J Med Virol; 2012 Oct; 84(10):1553-7. PubMed ID: 22930502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of short-course antenatal antiretroviral therapy on viral load and mother-to-child transmission in subsequent pregnancies among HIV-infected women.
    French CE; Tookey PA; Cortina-Borja M; de Ruiter A; Townsend CL; Thorne C
    Antivir Ther; 2013; 18(2):183-92. PubMed ID: 23475123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot programme for the rapid initiation of antiretroviral therapy in pregnancy in Cape Town, South Africa.
    Myer L; Zulliger R; Black S; Pienaar D; Bekker LG
    AIDS Care; 2012; 24(8):986-92. PubMed ID: 22519561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized controlled trials: differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count.
    Omer SB;
    AIDS; 2011 Mar; 25(6):767-76. PubMed ID: 21330912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.
    Kouanda S; Tougri H; Cisse M; Simpore J; Pietra V; Doulougou B; Ouedraogo G; Ouedraogo CM; Soudre R; Sondo B
    AIDS Care; 2010 Jul; 22(7):843-50. PubMed ID: 20635248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of maternal mortality with highly active antiretroviral therapy in a large cohort of HIV-infected pregnant women in Malawi and Mozambique.
    Liotta G; Mancinelli S; Nielsen-Saines K; Gennaro E; Scarcella P; Magid NA; Germano P; Jere H; Guidotti G; Buonomo E; Ciccacci F; Palombi L; Marazzi MC
    PLoS One; 2013; 8(8):e71653. PubMed ID: 23990966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and challenges of scaling up comprehensive PMTCT services in rural Swaziland, Southern Africa.
    Bancheno WM; Mwanyumba F; Mareverwa J
    AIDS Care; 2010 Sep; 22(9):1130-5. PubMed ID: 20824565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low prevalence of renal dysfunction in HIV-infected pregnant women: implications for guidelines for the prevention of mother-to-child transmission of HIV.
    Myer L; Kamkuemah M; Kaplan R; Bekker LG
    Trop Med Int Health; 2013 Nov; 18(11):1400-5. PubMed ID: 24102663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.